| Accession Number: | 0001209191-20-044579 |
| Date: | 2020-08-02 |
| Issuer: | AMNEAL PHARMACEUTICALS, INC. (AMRX) |
| Original Submission Date: |
MEISTER PAUL M
C/O AMNEAL PHARMACEUTICALS, INC.
400 CROSSING BOULEVARD
BRIDGEWATER, NJ 08807
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| CLASS A COMMON STOCK | 2020-08-02 | M | 27,923 | a | $0.00 | 27,923 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RESTRICTED STOCK UNITS | 0.0 | 2020-08-02 | deemed execution date | M | 27,923 (d) | class a common stock 27,923 | $0.00 | 0 | direct |
| ID | footnote |
|---|---|
| f1 | each restricted stock unit represents a contingent right to receive one share of the issuer's class a common stock. |
| f2 | on august 2, 2019, the reporting person was granted 27,923 restricted stock units vesting on august 2, 2020. |
